Considerations for High Dose Nitrates in Chronic Kidney Disease

Introduction to Nitrates in CKD

High dose nitrates should be used with caution in patients with CKD due to increased risk of adverse effects including orthostatic hypotension, worsening renal function, and methemoglobinemia 1

Nitrates undergo bioconversion to nitric oxide (NO) in both endothelial cells and myocytes, causing vasodilation that can reduce preload and afterload 2
The risk of adverse effects increases with declining renal function, particularly in advanced CKD (stages 4-5) 1

High dose nitrates can cause significant vasodilation leading to orthostatic hypotension, especially in elderly CKD patients 1
High dose nitrates can cause reduced renal perfusion that may worsen kidney function 3
High dose nitrates can cause headaches, flushing, and dizziness 1
Excessive hypotension may lead to prerenal azotemia and further deterioration of renal function 3
Blood pressure monitoring is essential during nitrate therapy in CKD patients 1, 4

Use the smallest effective dose for symptom relief in CKD patients 1
Nitrate tolerance may develop during continuous therapy, requiring dose adjustments or nitrate-free intervals 5

In patients with CKD and acute coronary syndromes, nitrates can be beneficial for symptom relief but require careful hemodynamic monitoring 5
For angina relief in CKD patients, short-acting nitrates are recommended for immediate symptom control 4, 6
Long-acting nitrates should be considered as add-on therapy when beta-blockers and/or calcium channel blockers fail to control angina symptoms 4, 6
Nitrates may be used in combination with hydralazine in selected heart failure patients with CKD 7
Routine use of nitrates is not recommended for heart failure with preserved ejection fraction (HFpEF) based on the NEAT-HFpEF trial 8

Avoid nitrates in patients with severe anemia or increased intracranial pressure 1
Do not use nitrates with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) due to risk of severe hypotension 5, 6
Use with extreme caution in patients with advanced CKD (eGFR <30 mL/min) due to altered drug metabolism and increased sensitivity to hemodynamic effects 1